美国 · SEC FORM 4
Hyperfine, Inc.
HYPR · Nasdaq · CIK 0001833769 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
4 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-12-14 · Sainz Maria.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,901,393
- 上期报告
- 4,236,754
- 日均成交量
- 461,116
- 回补天数
- 8.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-12-14 | Sainz Maria | 买入 (P) | Class A Common Stock | 5,000 | USD 0.95 | USD 4,750 | SEC 申报 ↗ |
| 2022-12-09 | Sainz Maria | 买入 (P) | Class A Common Stock | 12,425 | USD 0.85 | USD 10,561 | SEC 申报 ↗ |
| 2022-12-08 | Sainz Maria | 买入 (P) | Class A Common Stock | 2,575 | USD 0.83 | USD 2,137 | SEC 申报 ↗ |
| 2022-11-30 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 229,215 | USD 0.82 | USD 187,956 | SEC 申报 ↗ |
| 2022-11-29 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 47,007 | USD 0.72 | USD 33,845 | SEC 申报 ↗ |
| 2022-11-15 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 31,139 | USD 0.92 | USD 28,648 | SEC 申报 ↗ |
| 2022-11-14 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 34,488 | USD 0.89 | USD 30,694 | SEC 申报 ↗ |
| 2022-08-16 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 64,213 | USD 1.48 | USD 95,035 | SEC 申报 ↗ |
| 2022-08-12 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 303,137 | USD 1.46 | USD 442,580 | SEC 申报 ↗ |
| 2022-06-14 | ROTHBERG JONATHAN M | 买入 (P) | Class A Common Stock | 52,848 | USD 2.26 | USD 119,436 | SEC 申报 ↗ |
| 2022-02-03 | Cohen Arthur Bruce; HC Sponsor LLC; Healey Joseph Patrick; HealthCor Group, LLC | 买入 (P) | Class A Common Stock | 21,947 | USD 4.00 | USD 87,788 | SEC 申报 ↗ |
| 2022-01-26 | Cohen Arthur Bruce; HC Sponsor LLC; Healey Joseph Patrick; HealthCor Group, LLC | 买入 (P) | Class A Common Stock | 78,053 | USD 3.75 | USD 292,699 | SEC 申报 ↗ |
| 2022-01-21 | Cohen Arthur Bruce; HC Sponsor LLC; Healey Joseph Patrick; HealthCor Group, LLC | 买入 (P) | Class A Common Stock | 25,000 | USD 4.50 | USD 112,500 | SEC 申报 ↗ |
| 2022-01-12 | Cohen Arthur Bruce; HC Sponsor LLC; Healey Joseph Patrick; HealthCor Group, LLC | 买入 (P) | Class A Common Stock | 8,410 | USD 6.57 | USD 55,254 | SEC 申报 ↗ |
| 2022-01-11 | Cohen Arthur Bruce; HC Sponsor LLC; Healey Joseph Patrick; HealthCor Group, LLC | 买入 (P) | Class A Common Stock | 2,913 | USD 6.73 | USD 19,604 | SEC 申报 ↗ |
Form 4 申报证据
8 transaction lines in the latest 365-day window; 91 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 7,345 | USD 0.85 | USD 6,243 | SEC 申报 ↗ |
| 2026-08-24 | HALE BRETT | 卖出 (S) | Class A Common Stock | 7,345 | USD 0.85 | USD 6,243 | SEC 申报 ↗ |
| 2026-05-26 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 6,047 | USD 1.65 | USD 9,978 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 7,345 | USD 0.85 | USD 6,243 | SEC 申报 ↗ |
| 2026-08-24 | HALE BRETT | 卖出 (S) | Class A Common Stock | 7,345 | USD 0.85 | USD 6,243 | SEC 申报 ↗ |
| 2026-05-26 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 6,047 | USD 1.65 | USD 9,978 | SEC 申报 ↗ |
| 2026-05-26 | HALE BRETT | 卖出 (S) | Class A Common Stock | 6,047 | USD 1.65 | USD 9,978 | SEC 申报 ↗ |
| 2026-03-23 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 24,188 | USD 1.21 | USD 29,267 | SEC 申报 ↗ |
| 2026-03-23 | HALE BRETT | 卖出 (S) | Class A Common Stock | 24,188 | USD 1.21 | USD 29,267 | SEC 申报 ↗ |
| 2026-02-13 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 821 | USD 1.11 | USD 911 | SEC 申报 ↗ |
| 2025-11-19 | TEISSEYRE THOMAS | 卖出 (S) | Class A Common Stock | 1,405 | USD 1.08 | USD 1,517 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HYPR |
| CIK | 0001833769 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 91 transaction lines from 2021-12-22 to 2026-08-24 17 P purchase lines · 30 S sale lines · 44 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.